Old Web
English
Sign In
Acemap
>
Paper
>
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis.
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis.
2020
Donal B. O’Connor
Conor Lahiff
Keywords:
Ulcerative colitis
Gastroenterology
Adalimumab
Vedolizumab
Internal medicine
Surgery
Diabetes mellitus
Medicine
Infliximab
Colitis
Monoclonal
moderate to severe
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
3
Citations
NaN
KQI
[]